Financials • Investment Managers
$127.47 ▲ +3.65
(+2.95%)
MKT CAP: $42.10B • VOL: 2.39M
52W L $96 52W H $181
ARES // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $5.60B | $3.88B | $3.63B |
| YoY Revenue Growth % | +44.2% | +7.0% | — |
| Gross Profit | $2.46B | $1.71B | $1.60B |
| Gross Margin % | 44.0% | 44.0% | 44.0% |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $502.8M | $520.3M | $559.7M |
| Operating Margin % | 9.0% | 13.4% | 15.4% |
| Net Income (GAAP) | $426.1M | $441.0M | $474.3M |
| EBITDA (Normalized) | $704.5M | $660.2M | $690.5M |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $3.27B | $2.79B | -$233.3M |
| Capital Expenditures (CapEx) | $252.1M | $174.8M | $163.4M |
| Free Cash Flow (FCF) | $3.01B | $2.62B | -$396.7M |
| FCF Margin % | 53.8% | 67.3% | -10.9% |
| Return on Invested Capital (ROIC %) | 3.9% | 4.7% | 3.2% |
| Cash & Short-Term Equivalents | $3.15B | $2.74B | $2.55B |
| Total Debt (Short + Long Term) | $8.97B | $7.87B | $5.42B |
| Total Stockholders' Equity | $4.28B | $3.54B | $11.11B |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR ARES.